The current methods for distinguishing the zygosities of twins include ultrasound scanning, which is nondefinitive, and amniocentesis, which is invasive. We explored the use of massively parallel sequencing of maternal plasma DNA for the noninvasive prenatal assessment of the zygosities of twin pregnancies.
Twins can be either identical or fraternal. Identical twins are monozygotic, i.e., derived from the same fertilized egg. Fraternal twins are dizygotic (derived from 2 fertilized eggs). Monozygotic twins should be identical in their genetic makeup across the entire genome, whereas dizygotic twins are not genetically identical. It is of clinical importance to be able to distinguish the different types of twins for prenatal diagnosis. When fetuses from twin pregnancies are at risk for a genetic disease, prenatal testing would be necessary for each fetus of dizygotic twins. In contrast, a pair of monozygotic twins could theoretically be assessed for prenatal testing like a singleton pregnancy. When invasive prenatal diagnostic testing is required, having prior knowledge of the twin zygosity would allow one to determine whether chorionic villus sampling or amniocentesis is needed for each fetus (1) (2) (3) .
Ultrasound scanning may help in assessing the zygosities of twins by determining the fetal sex, chorionicity, and amnionicity of the 2 gestations (2 ). When ultrasonography reveals discordant external genital phenotypes, the twins are most likely dizygotic. When ultrasonography reveals the absence of a "twin-peak sign" indicating a monochorionic placenta, the twins are most likely monozygotic; however, a dichorionic diamniotic (DCDA) 4 placenta-as evidenced by the presence of a twin-peak sign and the same sex for both fetuses-is observed in at least 40% of all twin pregnancies and is compatible with both monozygotic and dizygotic twins. Furthermore, ultrasound assessment of fetal sex has limited accuracy in the first trimester (4 ) or when the fetuses present with ambiguous genitalia (5 ) . During the second trimester, the chorionic membranes will become thinner, and hence the absence of the twin-peak sign may be misleading (6 ) . In such situations, the proof of the zygosity of twins can be achieved only by genotypic analysis of genetic materials obtained from each twin. For example, amniocentesis could be performed to draw amniotic fluid from each amniotic sac to obtain amniocytes for genotypic analysis (3 ); however, amniocentesis is an invasive procedure that is associated with a finite risk of fetal miscarriage (7 ) .
Cell-free fetal DNA in maternal plasma represents a source of fetal genetic material that can be sampled noninvasively (8 ) . Its existence offers opportunities for noninvasive prenatal diagnosis, including Down syndrome detection (9 ) , but fetal DNA coexists in the mother's plasma with a large background of maternal DNA (10 ) . In twin pregnancies, the mother's plasma DNA profile is even more complex. DNA molecules from 3 individuals (i.e., the mother and the twin fetuses) coexist in maternal plasma. With the availability of massively parallel sequencing technology (11, 12 ) , a global survey of the fetal DNA profile in maternal plasma has been shown to be achievable (13, 14 ) . We describe a noninvasive approach for determining the zygosity of twins by looking for evidence of genetic differences between the twins, as inferred by differences in the apparent fractional fetal DNA concentrations across multiple genomic regions.
Materials and Methods

GENERAL PRINCIPLES
We used the genotypic differences between the fetuses and the mother to calculate fractional fetal DNA concentrations in maternal plasma (15 ) . The fractional fetal DNA concentration is the amount of fetal DNA expressed as a proportion of the amount of total genomic DNA present in a maternal plasma sample. We calculated fractional fetal DNA concentrations with data obtained from massively parallel sequencing of maternal plasma DNA. We analyzed the sequencing data to identify single-nucleotide polymorphism (SNP) loci that were covered by sequenced reads that showed Ͼ1 allele. We then applied an algorithm, FetalQuant, that we recently developed (16 ) to deduce the fetal and maternal genotype combination at the locus from the relative distributions of the 2 alleles among the sequenced reads. We then calculated the fractional fetal DNA concentration by using SNP sites deduced by the program to be homozygous in the mother but heterozygous in at least one of the fetuses. We termed such sites "informative SNP sites." Instead of determining the overall fractional fetal DNA concentration of the sample, however, we calculated multiple apparent fractional fetal DNA concentrations by using loci present in different genomic regions (Fig. 1) . Monozygotic twins are genetically identical. Therefore, values for the apparent concentration should be consistent across genomic Informative SNP loci, defined as sites for which the mother is homozygous and at least one fetus is heterozygous, are deduced from the distribution of the alleles in the DNA-sequencing data for maternal plasma. Values for the apparent fractional fetal DNA concentration (f ) were calculated with the formula shown ( p denotes the summed read count of the alleles with fewer counts at each informative SNP site; q denotes the summed read count of alleles with higher counts at each informative SNP site). Multiple f values calculated from loci present in different genomic regions were used to determine whether there is one or more than one distribution of f values.
regions. On the other hand, dizygotic twins are genetically nonidentical. Thus, there would be SNP loci where each twin would have different genotypes. That would lead to different values for the apparent fractional fetal DNA concentration across genomic regions, depending on whether the twins were genotypically concordant or discordant for the loci used in the calculations. We used the profile of the apparent fractional fetal DNA concentrations to infer the zygosities of the twins.
STUDY PARTICIPANTS AND SAMPLE COLLECTION
With informed consent, we recruited 8 twin pregnancies, including 4 sets of DCDA twins, 3 sets of monochorionic diamniotic (MCDA) twins, and 1 set of monochorionic monoamniotic (MCMA) twins (Table  1) . Maternal peripheral blood samples were collected on a single occasion between 19 and 30 weeks of gestation into EDTA-anticoagulated blood tubes prior to any invasive obstetrics procedures. Cord blood was collected separately from each fetus after delivery. This study was approved by the Joint Chinese University of Hong Kong-Hospital Authority New Territories East Cluster Clinical Research Ethics Committee.
SAMPLE PROCESSING AND DNA EXTRACTION
Maternal blood samples were centrifuged at 1600g for 10 min at 4°C. The plasma portion was recentrifuged at 16 000g for 10 min at 4°C to remove any residual blood cells (17 ) . The blood cell portion was recentrifuged at 2500g for 5 min at room temperature to remove any residual plasma. Plasma DNA was extracted with the DSP DNA Blood Mini Kit (Qiagen). Cord blood DNA was extracted with the QIAamp DNA Blood Mini Kit (Qiagen). Plasma DNA was quantified by a ␤-globin real-time PCR assay with an ABI 7300 Sequence Detector (Applied Biosystems). Genomic DNA extracted from blood cells was quantified with a NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies/Thermo Scientific).
MICROARRAY GENOTYPING
Genomic DNA extracted from cord blood samples was genotyped with the Affymetrix Genome-Wide Human SNP Array 6.0 system (Affymetrix). The degree of concordance in the genotypes observed for the 2 cord blood samples from each twin pregnancy was used to confirm if the twins were monozygotic or dizygotic.
PLASMA DNA LIBRARY PREPARATION AND TARGET
ENRICHMENT
DNA libraries were constructed with the Paired-End Sample Preparation Kit (Illumina), as previously described (15 ) . The amount of DNA used to prepare each library was 30 ng. These libraries were then subjected to target enrichment by means of the SureSelect Target Enrichment System (Agilent Technologies), as previously described (15, 18 ) The design of the capture probes took into account the GC content of the target region. The GC content of the probes was restricted to 47.5%-51.6%, thus minimizing GC bias in sequencing. We used the KAPA Library Quantification Kit (KAPA Biosystems) to quantify enriched libraries with a SYBR Green real-time PCR assay. Analysis with a 2100 Bioanalyzer (Agilent) confirmed the size distribution of the libraries.
SEQUENCING AND ALIGNMENT
All libraries were sequenced by the standard pairedend protocol (Illumina) on a Hi-Seq 2000 sequencer (Illumina), with a read length of 50 bp for each end. Each library was sequenced with 2 lanes of a sequencing (19 ) . We restricted the range of possible insert sizes to between 0 and 600 bp while allowing for 2 mismatches in each 50-bp sequenced read.
DETERMINATION OF THE APPARENT FRACTIONAL FETAL DNA CONCENTRATION FOR EACH CHROMOSOME
For further analysis, we selected the SNP loci that were deduced by FetalQuant (16 ) to be homozygous in the mother but heterozygous in the fetus. We calculated an apparent fractional fetal DNA concentration, f, for each chromosome on the basis of sequenced reads that aligned to the informative SNPs on the that chromosome, as follows:
where p is the combined read count of the alleles with fewer counts across the informative SNPs on the same chromosome, and q is the read count of the alleles with the higher counts at each informative SNP site combined across multiple sites on the same chromosome.
DETERMINATION OF REGIONAL VARIATION IN APPARENT FRACTIONAL FETAL DNA CONCENTRATIONS
We calculated the mean apparent fractional fetal DNA concentration for every 1000 informative SNPs on contiguous genomic blocks within the targeted regions. We evaluated whether these mean values would vary from block to block. Large fluctuations were expected for dizygotic twin pregnancies, because the informative SNP loci would consist of 2 categories, loci in which both fetuses were heterozygous (1 ) and loci in which only one of the twins was heterozygous (2 ) (Fig.  1) . The apparent fractional fetal DNA concentration calculated with the former category would be higher than that calculated with the latter. Because monozygotic twins are genetically identical, each fetus of a twin pair would be heterozygous at each informative SNP locus. Thus, the mean apparent fractional fetal DNA concentrations should be virtually identical across the genomic blocks.
To systematically detect the presence or absence of regional fluctuation in the apparent fractional fetal DNA concentrations, we first determined the random variation in values that could be observed even when no fluctuation was expected, such as with monozygotic twins. We assessed this baseline stochastic variation by computer simulation. We assumed that maternal plasma samples collected from monozygotic twin pregnancies contained at least 5% fetal DNA (20, 21 ) . Given a binomial distribution, there was therefore a 2.5% chance of detecting reads bearing the fetalspecific allele in maternal plasma for any particular informative SNP site. By simulating the occurrence of fetal-specific allele reads from the assumed probability and a mean sequencing depth of 100-fold, we estimated the maximal fluctuation in the fractional fetal DNA concentration in maternal plasma samples collected from monozygotic twin pregnancies. The simulation generated the same number of informative SNP sites as the experimental data set. We calculated the mean apparent fractional fetal DNA concentration by using 1000 SNPs per running window. We performed simulations 30 times to determine the lower and upper boundaries of the baseline stochastic variation.
For each maternal plasma sample, we then determined the proportion of the values for the mean apparent fractional fetal DNA concentration that deviated beyond the upper and lower boundaries of the baseline stochastic variation. We compared these proportions for the monozygotic and dizygotic twins.
DETERMINATION OF THE FRACTIONAL FETAL DNA CONCENTRATION FOR EACH TWIN FETUS
Next, we determined the fractional fetal DNA concentration for each fetus of pregnancies that showed regional variations in apparent fetal DNA concentrations and hence that we suspected of carrying dizygotic twins. For each set of twins, we observed the range of fetal DNA concentrations, as shown by every 1000 SNPs. Theoretically, the distribution of fractional fetal DNA concentrations should be characterized by 3 peaks (Fig. 2) . The peak with the highest fetal DNA concentration reflected the combined contributions from both fetuses, whereas the peaks with lower concentration values reflected the DNA contributions from individual fetuses. We also assumed that the amounts of the fetal-specific alleles for each fetus were binomially distributed. Hence, the overall distribution of the observed apparent fractional fetal DNA concentrations of both fetuses and the combined total concentration was governed by a mixture of the 3 binomial distributions. The analysis began with identifying the most likely location of the binomial distribution of the combined total fetal DNA contributions of the 2 fetuses. This location was identified by searching for the maximal mean apparent fractional fetal DNA concentration value across 1000-SNP windows. The remaining 2 binomial distributions, which corresponded to the fetal DNA fractions of each twin, were estimated by maximum likelihood. More specifically, we resolved the DNA concentrations of each of the 2 fetuses by the binomial-mixture model to identify the 2 peaks of fetal DNA concentration that have the highest likelihood of producing the known combined total amounts.
Results
CONFIRMATION OF TWIN ZYGOSITY BY GENOTYPIC ANALYSIS
We compared the genotypes across approximately 900 000 SNPs for the samples of cord blood from each twin pair to ascertain if the twins were monozygotic or dizygotic. We confirmed that the MCDA and MCMA twins were monozygotic because Ͼ99.6% of the SNP sites were concordant for each pair of twins. We concluded that all the DCDA twins in our cohort were dizygotic because the genotype concordance rates were 75.6%-80.3% (Table 1) .
DISTRIBUTIONS OF APPARENT FRACTIONAL FETAL DNA CONCENTRATIONS BETWEEN CHROMOSOMES
We sequenced a median of 431 ϫ 10 6 raw paired-end reads (range, 418 ϫ 10 6 to 456 ϫ 10 6 ) per sample and obtained a median of 330 ϫ 10 6 aligned paired-end reads (range, 228 ϫ 10 6 to 359 ϫ 10 6 ) per sample. Paired-end reads with identical start and end coordinates in the genome were removed. We achieved a median of 530-fold coverage (range, 346-to 835-fold) for each SNP locus for each sample. We used the informative SNPs identified by FetalQuant to calculate the apparent fractional fetal DNA concentrations across chromosomes for each maternal plasma DNA sample. The median number of informative SNPs was 7250 (range, 6495-8409), and 97% of these SNPs were concordant with the microarray data. We determined the mean, SD, and range for the apparent fractional fetal DNA concentrations among the chromosomes for each case. The apparent fractional fetal DNA concentration was relatively constant across chromosomes for all sets of monozygotic twins, with SD values ranging 
Fig. 2. Schematic diagram illustrating the determination of the fractional fetal DNA concentration for each fetus in the twin pair.
The x axis is the apparent fractional fetal DNA concentration in the 1000-SNP windows. The y axis is the frequency at which a particular fetal DNA concentration occurs. The distribution of fractional fetal DNA concentrations is characterized by 3 peaks. The peak with the highest apparent fractional fetal DNA concentration (f) reflects the combined contributions from both fetuses (f 1 ϩ f 2 ). The underlying genotypes for this value include the mother (AA), fetus I (AB), and fetus II (AB). The peaks with lower concentration values reflect the DNA contributions of individual fetuses (f 1 or f 2 ). The underlying genotypes for these values include the mother (AA), fetus I (AA), and fetus II (AB); or the mother (AA), fetus I (AB), and fetus II (AA). The concentration for f 1 ϩ f 2 is identified by searching for the maximal mean f value across windows of 1000 SNPs (f max ). Because f max ϭ f 1 ϩ f 2 , we obtain f 2 ϭ f max Ϫ f 1 ; consequently, only 1 variable, f 1 , needs to be determined. The binomial-mixture model is used to resolve f 1 to determine the fetal DNA concentration that has the highest likelihood of producing the known combined total amounts (f max ).
from 0.82 to 1.35 (Fig. 3A) . The corresponding SD values for the dizygotic twin cases ranged from 2.42 to 4.80 (Fig. 3B) . The differences between the 2 groups in SD values were significant (P Ͻ 0.05, Mann-Whitney U-test).
REGIONAL VARIATIONS IN MEAN APPARENT FRACTIONAL FETAL
DNA CONCENTRATIONS
To systematically assess the variation among apparent fractional fetal DNA concentrations, we standardized the basis of calculating each apparent value to the use of 1000 informative SNPs. The monozygotic and dizygotic twin pregnancies differed with respect to the proportions of data points lying outside the limits of the stochastic background variation estimated by computer simulation (Fig. 4) . For the monozygotic twin pregnancies, most of the data points fell within the boundaries of the stochastic background; the proportions of the data points that fell outside the boundaries ranged from 0.00% to 1.93%. For the dizygotic twin pregnancies, the proportions of the data points that fell outside these boundaries were larger, ranging from 36.2% to 78.1% (Fig. 4) .
We performed another simulation analysis to investigate whether this approach would be useful for samples with lower fractional concentrations of fetal DNA in maternal plasma, e.g., for samples collected during earlier gestational ages. Zygosity status can still be predicted accurately when the fractional DNA concentration of each fetus is Ͻ5% (see Fig. 1 in the Data Supplement that accompanies the online version of this article at http://www.clinchem.org/content/vol59/ issue2). Table 2 shows the estimated fractional fetal DNA concentrations for each twin fetus in the 4 dizygotic cases. We retrieved the microarray-based genotype information for each individual twin and identified the SNPs that were informative for each member of a twin pair. The massively parallel sequencing data covering these confirmed informative SNPs were then retrieved to calculate the fractional fetal DNA concentration of each individual of a dizygotic twin pair. The concentrations estimated with binomial-mixture statistics were consistent with those calculated with the known fetalgenotype information (Table 2) .
FRACTIONAL FETAL DNA CONCENTRATIONS OF MEMBERS OF DIZYGOTIC TWINS
Discussion
We developed a method to assess the zygosities of twins by demonstrating the presence of regional variations in apparent fractional fetal DNA concentrations between dizygotic twins. The presence of such variations reflects the existence of genotypic differences between the 2 fetuses of dizygotic twins. This study is the first to assess the zygosities of twins objectively and noninvasively via genetic means. Our method is safer than amniocentesis, and it is more conclusive than ultrasound scanning, which can present both monozygotic and dizygotic twins as DCDA twins. To be able to determine the zygosity of twins is of clinical value. Monozygotic twins generally have a higher risk of obstetric complications The apparent fractional fetal DNA concentrations calculated on the basis of loci from individual chromosomes are plotted by chromosome for monozygotic cases (A) and dizygotic cases (B). The degree of variation in the apparent fractional fetal DNA concentration for each twin pair is determined by calculating the SD of the fractional fetal DNA concentrations across chromosomes. The SD value for each case of twins is shown at the end of each curve. The case numbers are given below the plots. (22 ) , such as twin-twin transfusion, than dizygotic twins. Furthermore, the zygosity of twins has implications for prenatal genetic testing. Monozygotic twins can be assessed like singleton pregnancies, whereas each fetus of a dizygotic twin pair needs to be assessed individually.
Noninvasive prenatal diagnosis of fetal chromosomal aneuploidies has been achieved with the use of massively parallel sequencing of maternal plasma DNA (20, 21, 23, 24 ) . Canick et al. (25 ) recently applied the protocol, which had originally been validated with singleton pregnancies, for the testing of multifetus pregnancies. These authors showed that increased amounts of chromosome 21 DNA molecules were present in the maternal plasma for 2 sets of twins in which both fetuses had Down syndrome and for 5 sets of twins in which only one of the twin fetuses had Down syndrome. Down syndrome was correctly excluded in 17 sets of twins and 2 sets of triplets who had been confirmed to be karyotypically normal. Although the data are encouraging, it would be ideal if the zygosities of the twins had been known before aneuploidy testing. The diagnostic sensitivity of DNA sequencing of maternal plasma for detecting aneuploidy is governed by the fractional fetal DNA concentration of the affected fetus (20, 21 ) . The increase in chromosomal representation could be detected more readily for maternal plasma samples containing higher fractional fetal DNA concentrations. In contrast, samples with low fractional fetal DNA concentrations may lead to false-negative results. Thus, knowing the fractional fetal DNA concentration contributed by a fetus to be tested is useful for predicting the likely sensitivity of the sequencing test for aneuploidy. This consideration also applies to twin pregnancies. The method we developed in the present study provides the objective information needed for interpreting the noninvasive aneuploidy test for twin pregnancies. The method we have described can be used to objectively distinguish monozygotic twins from dizygotic twins. When the data suggest monozygosity, the noninvasive aneuploidy test could be applied, as long as the total fractional fetal DNA concentration exceeds the minimum stipulated by the test protocol, e.g., 4% (21) . When the data suggest dizygosity, determining the fractional fetal DNA concentration of each fetus would be necessary. We have described the use of the binomial-mixture approach to estimate the fetal DNA contribution of each fetus of dizygotic twins. The noninvasive aneuploidy test would be applicable if the fetus contributing the lesser amount of fetal DNA also had a value that reached the minimum requirement. In short, instead of assuming that there are adequate amounts of fetal DNA from each twin fetus, as Canick et al. have done (25 ) , the approach developed in our study provides an objective means of determining twin zygosity and the DNA contributions of individual fetuses of dizygotic twins. Besides the capability to assess chromosomal aneuploidy, the ability to measure the fetal DNA contributions of individual fetuses of dizygotic twins could serve as a useful internal positive control for any tests based on analyzing circulating fetal DNA in maternal plasma for these pregnancies, such as noninvasive fetal RHD genotyping (26 ) and singlegene disease diagnosis (13, 27, 28 ) .
In addition to serving as a guide to or an internal control for the interpretation of prenatal genetic tests, the ability to measure the DNA contribution of an individual fetus of dizygotic twins might also allow one to monitor the well-being of each twin. A number of pregnancy-related complications are known to be associated with abnormal concentrations of circulating fetal DNA (29, 30 ) . In theory, our method should be applicable to other forms of multifetus pregnancies, such as triplets.
On the other hand, when apparent fetal DNA concentrations are observed along genomic coordinates, such as in blocks of 1000 consecutive informative SNPs, the loci where concentration values change would indicate sites where each dizygotic fetus inherited a different paternal haplotype. Such loci are the sites of recombination in the paternally inherited genome. Thus, measurement of the apparent fetal DNA concentration could be used to identify genomic regions shared by dizygotic twin fetuses and regions where they differ.
We studied maternal plasma samples collected between 19 and 30 weeks of gestation. Theoretically, the method should be applicable to first-trimester blood samples, because FetalQuant has been shown to predict correct maternal and fetal genotypes even in firsttrimester samples (16 ) . Our simulation analysis further verified this point (see Fig. 1 in the online Data Supplement).
Although we performed this study by using target enrichment followed by massively parallel sequencing, the method could be performed with other methods for quantifying alleles, such as digital PCR (27, 28 ) . For example, a panel of digital PCR assays could be designed to target SNPs for which the mother is known to be homozygous, with the aim of measuring the relative concentrations of the nonmaternal alleles. Alternatively, a panel of digital PCR assays could be designed to target a panel of highly polymorphic SNPs, followed by identification of the informative SNPs with FetalQuant analysis of the maternal-plasma data. Dizygotic twins would be suspected when the relative concentrations of the fetal alleles are shown to vary widely among SNP sites.
In summary, by determining and comparing the apparent fractional fetal DNA concentrations of different genomic regions, we can determine the zygosity of twins. The method also allows the determination of contributions to the circulating fetal DNA by individual fetuses of dizygotic twins. These developments have many potential uses in the clinic and in research and might improve the obstetric management of multifetus pregnancies. 
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